Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jul;68(6):737-744.
doi: 10.1111/aas.14413. Epub 2024 Mar 24.

Prolonged duration of action of suxamethonium in pregnant and postpartum patients: A registry study

Helene Dalsten  1 , Vera Crone  2 , Jacob Steinmetz  1   3   4 , Christine L Rosager  5   6 , Lars S Rasmussen  7 , Matias Vested  1   4
Affiliations

Prolonged duration of action of suxamethonium in pregnant and postpartum patients: A registry study

Helene Dalsten et al. Acta Anaesthesiol Scand. 2024 Jul.

Abstract

Background: Suxamethonium is hydrolysed by butyrylcholinesterase (BChE) and a low BChE activity can result in a prolonged duration of action of suxamethonium. The BChE activity is reduced during pregnancy and postpartum period by up to 33%. However, it can also be reduced by mutations in the BChE gene. In this study, we assessed BChE activity and mutations in the BChE gene in pregnant and postpartum patients with prolonged duration of action of suxamethonium. It was hypothesised that at least 30% of patients with a low BChE activity did not have a mutation in the BChE gene.

Methods: In this registry study we focused on pregnant and postpartum patients with a history of prolonged duration of action of suxamethonium referred to the Danish Cholinesterase Research Unit (DCRU) between March 2007 and January 2023. Primary outcome was the proportion of patients without a mutation among patients with a low BChE activity. Secondary outcomes were the proportion of patients with a low BChE activity and the proportion of patients with a mutation out of the total number of patients.

Results: A total of 40 patients were included and among patients with a low BChE activity, 6% (95% CI: 1%-21%) did not have a mutation. Out of the total number of included patients referred to the DCRU, 90% (95% CI: 76%-97%) had a mutation and 94% (95% CI: 80%-99%) had a low BChE activity.

Conclusion: Among pregnant and postpartum patients with a history of prolonged duration of action of suxamethonium and a low BChE activity, 6% did not have a mutation in the BChE gene. Our findings suggest that during pregnancy and postpartum clinically relevant prolonged duration of action of suxamethonium rarely occurs in genotypically normal patients.

Keywords: butyrylcholinesterase; neuromuscular blockade; postpartum; pregnancy; pseudocholinesterase; suxamethonium.

PubMed Disclaimer

References

REFERENCES

    1. Jensen AG, Callesen T, Hagemo JS, Hreinsson K, Lund V, Nordmark J. Scandinavian clinical practice guidelines on general anaesthesia for emergency situations. Acta Anaesthesiol Scand. 2010;54:922‐950.
    1. Fuchs‐Buder T, Romero CS, Lewald H, et al. Peri‐operative management of neuromuscular blockade: a guideline from the European Society of Anaesthesiology and Intensive Care. Eur J Anaesthesiol. 2023;40:82‐94.
    1. Guay J, Grenier Y, Varin F. Clinical pharmacokinetics of neuromuscular relaxants in pregnancy. Clin Pharmacokinet. 1998;34:483‐496.
    1. Baron TH, Ramirez B, Richter JE. Gastrointestinal motility disorders during pregnancy. Ann Intern Med. 1993;118:366‐375.
    1. Evans FT, Gray PWS, Lehmann H, Silk E. Sensitivity to succinylcholine in relation to serum‐cholinesterase. Lancet. 1952;1:1229‐1230.

Substances

LinkOut - more resources